Sber Eapteka
Pharmacies
Since 2000
Russia
Central Federal District of the Russian Federation
Moscow
Frunzenskaya embankment, house 42
Top managers:
Anton Romanovich Buzdalin
Content |
SBERBANK EAPTEKA (until November 2020 - EAPTEKA) was founded in 2000 and works in the field of electronic sale and delivery of over-the-counter drugs and health products in Russia. In 2020, the Minis try of Digital Development of the Russian Federation included the SBER EAPTEKA service in the list of socially significant Internet resources.
Performance indicators
2020: Turnover - 11 billion rubles
The turnover of Sber Eapteka in 2020 exceeded 11 billion rubles.
History
2024: Eapteka employee received 2 years in prison for stealing 300 thousand rubles from a safe
On March 26, 2024, the Frunzensky District Court of St. Petersburg announced the verdict against Anton Saratov, the senior shift of the pharmacy of Eapteka LLC. The man was found guilty of committing a crime under Part 3 of Article 160 of the Criminal Code of the Russian Federation (misappropriation or embezzlement). Read more here.
2023
Joining the "Rigla" pharmacy pickup network
SBERBANK EAPTEKA has entered into a partnership agreement with Rigla, 2400 outlets of which have joined the network of partner pick-up points. Sberbank Apteka announced this on September 7, 2023.
Now SBER EAPTEKI customers have more options to receive online orders on their usual routes, saving time.
SBER EAPTEKA systematically audits promising partner pharmacies. It is important for the company that customers receive the highest quality service at all stages: from the choice of health and beauty products on the site or in a simple and understandable application with an intuitive interface - to the timely and quick receipt of an order at a pharmacy point with high customer service standards.
Шаблон:Quote 'author = said Yulia Ermakova, Operations Director of SBER EAPTEKI.
Over the year, SBER EAPTEKA doubled the total number of pickup points to 13,544.
Receiving penalty for false advertising
The Federal Antimonopoly Service (FAS) of Russia recognized inappropriate advertising from the ePharmacy service and ordered to stop the violation. The department announced this in its Telegram channel on January 23, 2023.
A resident of Russia appealed to the FAS with a complaint about inappropriate advertising from the ePharmacy application, which the user saw on the VKontakte social network. In the commercial, the consumer was promised a discount when introducing a special promotional code after downloading the application. In practice, it turned out that in order to receive a discount, you also need to be a new customer and make an order for a certain amount from the proposed assortment. Thus, significant conditions for obtaining a discount were hidden in advertising from consumers, which misled them, the department said.
The FAS recognized the advertising from ePharmacy as improper and ordered to stop the violation. Also, the antimonopoly regulator imposed a fine on the company, the amount of which was not disclosed.
 | The service will continue comprehensive work to protect citizens from unreliable advertising, the FAS added. |  |
By January 2023, ePharmacy is one of the largest online pharmacies in Russia. The audience of the service (site and application) exceeds 18.5 million people a month, the assortment has more than 50,000 items of goods.
Earlier, the Russian Association of Pharmacy Chains (RAAS) complained to the Prosecutor General's Office about Eapteka and the Здоров.ру chain, saying that online stores sell drugs without prescriptions. In its appeal, RAAS claims that Eapteka is engaged in the remote sale of Azitrox, Clarithromycin-OBL, Methotrexate and Triazivirin. Eapteka shifts possible risks to the buyer, violating the rules for the delivery of drugs, the RUSS said.[1]
2021
Maria Timofeeva - the new head of Sber Eapteki
In December 2021, it became known about the appointment of Maria Timofeeva to the post of general director of Sber Eapteki. In this post, she will replace Anton Buzdalin, who, as vice president of the company, will focus on strategic business development. Read more here.
The start of drug sales in branches of Sber Bank
On April 27, 2021, it became known that Sberbank was preparing to start selling medicines in its bank branches. On the basis of the offices of the largest credit institution in Russia, Sber Eapteki points will open. Previously, the Sber Eapteka service existed only online.
| | If we see that our customers like the opportunity to combine a trip to the bank with a visit to a pharmacy, then we will expand this, "said Lev Khasis, First Deputy Chairman of the Board of Sberbank (quoted by TASS), adding that while we are talking about a pilot project. | |
According to Hasis, the bank will be able to provide the pharmacy with space on preferential terms, so drug prices will be lower. The top manager of Sberbank also noted that one of the directions to increase the availability of drugs will be the possibility of their metered sale.
Very often, a doctor recommends buying a medicine, and there, for example, there are 50 tablets, of which we need to use five, and we need to pay for the entire package, the first deputy chairman explained. Therefore, the pharmacy wants to give the opportunity to buy exactly as many tablets as the doctor prescribed.
Sberbank Eapteka will also work on the production of drugs of its generic brands, as a result they can be cheaper than ordinary ones, the price of which is 80% formed by advertising, Hasis said.
By April 2021, Sber Eapteka is the second most profitable online service for ordering drugs after Аптеки.ру in Russia. The company operates in 70 cities of Russia, and its assortment has about 70 thousand positions.
It is expected that Sber Eapteka will join the implementation of a pilot project for the online sale of prescription drugs, which will be held in the Belgorod region.[2]
Use of the area of the bankrupt pharmaceutical distributor "Growth" as a distribution center
As it became known at the end of March 2021, the Sber Eapteka company occupied the areas of the bankrupt pharmaceutical distributor Rosta. We are talking about an industrial site in the Konnaya Lakhta industrial park, which the "daughter" of Sberbank will use for a distribution center. The financial terms of the transaction were not disclosed. Read more here.
Completion of the transaction "Sberbank" and "R-Pharm" on investing in "Sberbank Eapteka"
On February 10, 2021, Sber Eapteka informed Zdrav.Expert about the completion of the transaction for joint investment in it between Sberbank and the R-Pharm group of companies.
Photo source: m.realnoevremya.ru
Sberbank and the R-Pharm Group of Companies each received 45% of the company's shares, while Anton Buzdalin, founder and CEO of Sber Eapteki, retained 10%. The amount of Sberbank's investments in the framework of the transaction amounted to 5.7 billion rubles. and will be aimed at the development of the company (cash-in) - improving the quality of service and expansion into the regions of Russia, which Sberbank Eapteka began in 2020. In 2021, it is planned to launch in 76 more cities of the country, in many of them the purchase of drugs with delivery will be available for the first time.
Sberbank Eapteka is developing as a personalized health care service, where you can not only purchase medicines, but also receive medical appointments and additional services. The company will ensure that drug prices remain low by optimizing costs and using the infrastructure of the Sberbank ecosystem.
The joint investment in the company was first announced in October 2020. Since November 2020, the Eapteka company has been operating as part of the Sberbank ecosystem and is developing under the Sber Eapteka brand. As part of the cooperation between Sber and Sber Eapteki, a deep integration into the Sber ecosystem is carried out. The company became part of the SberPrime subscription. Customers are available authorization by Sber ID and payment by. In SberPay the future, it will be possible to charge and write off bonuses, SberThank you as well as order drugs using smart Sberbank devices.
Since 2020, Sber Eapteka has been developing a system of hub pharmacies designed for online sales. By reducing the load on the central warehouse and serving the nearest areas, they allow for urgent delivery within an hour. As of February 2021, 15 hubs are operating in Moscow and the Moscow Region, providing delivery per hour within the Third Transport Ring and other districts of the city. The plans for 2021 include the opening of another 25 hubs, due to which the delivery service will become available in an hour throughout Moscow and the Moscow region.
| | We have completed a deal to invest in a modern digital pharmacy, this was one of the consecutive steps in the development of the healthcare and e-commerce industry in the Sberbank ecosystem. Our SberHealth services provide the full range of medical services and services for maintaining and caring for health. I am sure that our joint expertise and experience will not only strengthen the position of Sber Eapteki in the market, but also give impetus for large-scale development, said Lev Khasis, First Deputy Chairman of the Management Board of Sberbank
| |
| | Cooperation with Sber and R-Pharm opened up additional opportunities for the development of Sber Eapteki. By integrating into the Sberbank ecosystem and synergy with other services, we improve the quality of our services, providing seamless customer experience and improving the delivery system. Sberbank is a brand that is trusted in the regions. His reputation, combined with the experience of Sber Eapteka in the field of online drug sales, allows us to talk about great prospects for regional expansion, noted Anton Buzdalin, founder and general director of Sber Eapteki
| |
{{quote 'author = specified Alexey Repik, Chairman of the Board of Directors of R-Pharm|Over the past year, a new consumer pattern has finally taken hold in the company. The remote purchase of medicines and medical devices is becoming more and more familiar to millions of citizens of the country every day. We intend to offer a convenient, high-quality and safe tool for these purposes, based on the expertise of Sber Eapteki in pharmacy retail, expertise and technologies of Sber, R-Pharm's experience in the creation and logistics of high-tech drugs. Such convergence should allow Sber Eaptek to take a high position in the market for online sales of medicines and health products in the near future. }}
2020
The company's turnover in 2020 exceeded 11.0 billion rubles, showing an increase of 96% compared to last year.
Name change to Sber Eapteka
On November 11, 2020, Eapteka, one of the Internet pharmacies in Russia, announced a name change to SBER EAPTEKA and becomes part of the Sberbank ecosystem.
The rebranding process of SBER EAPTEKI will take six months. Changes in logo and corporate identity will primarily affect the company's website and application: customers will be able to see the updated logo on November 11, 2020. The full rebranding, including the design of signs and points of sale, will be completed in the first quarter of 2021.
At the same time, SBER EAPTEKA will be integrated into the Sber ecosystem. The company is already represented in the basic subscription of SberPrime, which provides discounts on ecosystem services. Since November 11, for customers of SBER EAPTEKI, who are subscribers of SberPrime, free delivery has been working when ordering in the amount of 500 rubles or more. At the first stage - in Moscow, St. Petersburg and Tver. Over time, the service will spread to other cities of Russia, which have delivery from SBER EAPTEKI. To access the service, the client needs to purchase a SberPrime subscription and register with SBER EAPTEKE using Sber ID.
Anton Buzdalin, General Director of SBER EAPTEKA:
| | Cooperation with such a technology giant as Sberbank gives us opportunities to develop the company - and, accordingly, further improve the quality of service. Connecting to SberPrime and participating in Green Day are only the first steps, but thanks to them, program subscribers and customers will be able to appreciate the speed and convenience of delivery from SBER EAPTEKI. In the future, we plan to take SBER EAPTEKI services beyond delivery and turn the company into a powerful health care service: with medical consultations and personalized selection of drugs. | |
Acquisition of stakes in Sberbank and R-Pharm
On October 22, 2020, Eapteka told Zdrav.Expert that as part of the transaction, Sberbank and the R-Pharm Group of Companies, after receiving the necessary antitrust approvals, will acquire 45% of the company's shares, while the founder and CEO of Eapteka Anton Buzdalin will retain 10%.
The main goal of creating the Sberbank ecosystem is the development of services in the interests of each person and high standards of service quality. In 2017, Sberbank began investing in the healthcare industry.
As of October 2020, SberHealth services combine telemedicine consultations, a doctor's appointment, health support products and treatment support.
The appearance of a digital pharmacy in this row is a consistent step towards the development of SberHealth.
Medicines for Eapteka guarantee the quality of the product and protection against counterfeiting in the interests of ensuring the health of each client.
Eapteka is one of the representatives of the sphere of electronic sale and delivery of over-the-counter drugs and health products in Russia. The service range for October 2020 consists of about 70,000 goods, the monthly number of active users of Eapteka is more than 4 million people, and the company's annual turnover in 2019 exceeded 5.7 billion rubles, taking into account the franchise project. For the nine months of 2020, sales growth year-on-year through the site amounted to 146%, through the application - 158%.
The company will operate under the Sber Eapteka brand.
Closing of the transaction is expected in the IV quarter of 2020.
Sberbank and Eapteka have launched joint initiatives to promote the service. Within the framework of the cooperation, it is planned to deeply integrate Eapteka into the Sberbank ecosystem. The sale of drugs will be integrated into SberHealth, SberLogistics, SberPrime, as well as synergies with other assets and services of the Sber ecosystem. Joint integration of Eapteka pharmaceutical products with SberHealth services will allow the client to receive the necessary high-quality medicines in addition to competent medical advice. When registering with Eapteki services, the use of Sberbank ID will be available, and in the future customers will be able to become members of the Thank You loyalty program.
{{quote 'author = said German Gref, President, Chairman of the Management Board of Sberbank' Health is the main value for any person, and the task of SberHealth is to create opportunities for prevention, health support and high-quality treatment if necessary. We already have telemedicine services, a doctor's appointment, a doctor's call at home. Sberbank announced the most important goal - to provide our customers with high-quality medicines. We are pleased that R-Pharm Group is our partner and together we invest in such a strong company as Eapteka. Eapteka services guarantee the opportunity to get reliable and proven drugs. Eaptek has a large staff of highly qualified pharmacists, and the company has all the necessary competencies to become a market leader with our joint support, }}
Partnership contract with CSKA signed
On August 15, 2020, Eapteka announced that it had become a partner of the CSKA Professional Football Club. The contract was signed for the 2020-2021 season. As an online supplier of health products, Eapteka supports events that contribute to the popularization of an active lifestyle. The company concludes a sponsorship contract with a football club for the first time, the company noted. Read more here.
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |